NCT06756737View on ClinicalTrials.gov

The Application of 68Ga-Pentixafor Alongside 68Ga-FAPI-04 PET/MR for Assessing Primary Aldosteronism.

Not yet recruitingOBSERVATIONAL

Enrollment

60

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions

Primary Aldosteronism

All Listed Sponsors

lead

Shanghai East Hospital

OTHER

NCT06756737 - The Application of 68Ga-Pentixafor Alongside 68Ga-FAPI-04 PET/MR for Assessing Primary Aldosteronism. | Biotech Hunter | Biotech Hunter